Background -Glutaraldehyde is the best disinfectant for fibreoptic endoscopes. It is also used in the processing ofx ray films. A number of studies have reported eye, nose, and respiratory symptoms in exposed workers. Three individual case reports ofoccupational asthma in endoscopy workers and a radiographer have also been published. We describe a further seven cases ofoccupational asthma due to glutaraldehyde in endoscopy and x ray departments, together with exposure levels measured during the challenge tests and in 19 endoscopy and x ray departments in the region. Methods -Eight workers were referred for investigation ofsuspected occupational asthma following direct or indirect exposure to glutaraldehyde at work. They were investigated by serial measurements of peak expiratory flow (PEF) and specific bronchial provocation tests. Glutaraldehyde levels were measured using personal and static short and longer term air samples during the challenge tests and in 13 endoscopy units and six x ray darkrooms in the region where concern about glutaraldehyde exposure had been expressed. Three of the workers investigated with occupational asthma came from departments where glutaraldehyde air measurements had been made; the others came from other hospitals or departments. Results -The diagnosis of occupational asthma was confirmed in seven workers, all ofwhom had PEF records suggestive of occupational asthma and positive specific bronchial challenge tests to glutaraldehyde. Bronchial provocation testing was negative in one worker who was no longer exposed and who had a less clearcut history of occupational asthma. Three workers also had a positive specific bronchial challenge to formaldehyde. The mean level of glutaraldehyde in air during the challenge tests was 0-068 mg/m3, about one tenth of the short term occupational exposure standard of0 7 mg/m3. The levels obtained in the challenge chamber were similar to those measured in 13 endoscopy suites and six x ray darkrooms where median short term levels were 0-16 mg/m3 during decantation in endoscopy suites and <0_009 mg/m3 in darkrooms. Conclusions -Glutaraldehyde can cause occupational asthma. The exposure levels measured in the workplace suggest that sensitisation may occur at levels below the current occupational exposure standard. (Thorax 1995;50:156-159) 
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Background -Glutaraldehyde is the best disinfectant for fibreoptic endoscopes. It is also used in the processing ofx ray films. A number of studies have reported eye, nose, and respiratory symptoms in exposed workers. Three individual case reports ofoccupational asthma in endoscopy workers and a radiographer have also been published. We describe a further seven cases ofoccupational asthma due to glutaraldehyde in endoscopy and x ray departments, together with exposure levels measured during the challenge tests and in 19 endoscopy and x ray departments in the region. Methods -Eight workers were referred for investigation ofsuspected occupational asthma following direct or indirect exposure to glutaraldehyde at work. They were investigated by serial measurements of peak expiratory flow (PEF) and specific bronchial provocation tests. Glutaraldehyde levels were measured using personal and static short and longer term air samples during the challenge tests and in 13 endoscopy units and six x ray darkrooms in the region where concern about glutaraldehyde exposure had been expressed. Three of the workers investigated with occupational asthma came from departments where glutaraldehyde air measurements had been made; the others came from other hospitals or departments. Results -The diagnosis of occupational asthma was confirmed in seven workers, all ofwhom had PEF records suggestive of occupational asthma and positive specific bronchial challenge tests to glutaraldehyde. Bronchial provocation testing was negative in one worker who was no longer exposed and who had a less clearcut history of occupational asthma. Three workers also had a positive specific bronchial challenge to formaldehyde. The mean level of glutaraldehyde in air during the challenge tests was 0-068 mg/m3, about one tenth of the short term occupational exposure standard of0 7 mg/m3. The levels obtained in the challenge chamber were similar to those measured in 13 Glutaraldehyde (pentan-1,5-dial, glutaric dialdehyde) is an aliphatic dialdehyde with a slightly acidic and powerful odour perceptible at 0 16 mg/m3 which causes nasal and eye irritation at levels above 1 23 mg/mr3. It is the best disinfectant for cold sterilisation of endoscopes, being active against bacteria, viruses and mycobacteria, and causes no damage to equipment.2 Glutaraldehyde is also a constituent of the developer used in x ray film processing, a fixative in electron microscopy, a biocide in cooling towers,3 a leather tanning agent, and a treatment for hyperhidrosis. 4 In hospital endoscopy suites it has often been used in an open environment with uncontrolled exposure to workers. A number of studies have described eye irritation, rhinitis, and symptoms of airways obstruction at exposure levels below the 10 minute short term exposure standard of 0 7 mg/m3.5-7 There have also been several case reports of respiratory symptoms due to glutaraldehyde in endoscopy workers8-l0 and one in a radiographer." These cases were diagnosed mainly by specific bronchial challenge. Glutaraldehyde is a recognised cause of occupational asthma for statutory compensation in the United Kingdom. '2 Despite these findings, there continues to be a degree of scepticism as to whether occupational asthma due to glutaraldehyde actually exists and, if so, whether it is due solely to an irritant effect. We have investigated a consecutive series of workers with direct or indirect exposure to glutaraldehyde referred to a specialist occupational lung disease clinic who were prepared to undergo occupational type bronchial provocation testing with glutaraldehyde exposure. We also performed controlled exposures to formaldehyde as several of the workers were also exposed to this chemical, and as occupational asthma due to formaldehyde is better described. We also report the exposure levels to glutaraldehyde from endoscopy and x ray departments in the region. These measurements were made at the request of the individual departments following concern about glutaraldehyde exposure. They are likely therefore to include more departments with above average exposures. Three of the workers investigated with confirmed occupational asthma came from departments where air measurements were made.
Methods
Subjects with exposure to glutaraldehyde and a history of asthmatic symptoms that improved when away from work were initially assessed by performing serial peak expiratory flow (PEF) measurements two hourly from waking to sleeping, at and away from work, over a four week period. These were then plotted'3 and interpreted by eye The results of breathing zone samples collected during three simulated specific bronchial challenge tests using 2% glutaraldehyde ranged from 0-064 mg/m3 to 0-081 mg/m3. Three out of four who had repeated measures of non-specific bronchial responsiveness showed increased responsiveness the day after the specific challenge to glutaraldehyde. Three workers also had positive late reactions on challenge to formaldehyde.
Thirty personal air samples were collected in 13 hospital endoscopy units. Twelve of these units employed manual methods of disinfection, simply immersing endoscopes in a bowl or trough of 2% glutaraldehyde solution; the remaining unit used an EW20 autodisinfector and, in this case, samples were collected whilst the disinfectant tank was drained to a bowl in front of the machine. The median value for personal short term samples was 0-16 mg/m3 (95% CI 0 12 to 0 68), for personal long term samples 0-041 mg/m3 (95% CI 0-016 to 0.14), and for static short term samples 0-17mg/m3 (95% CI 0-12 to 0-25). In one department a personal short term level of 2 6 mg/m3 was measured when glutaraldehyde solution was poured over a semi-automatic trolley three times in a poorly ventilated room. As this is not recommmended practice the results have not been included with the others which were measured when recommended procedures were being followed. A summary of the airborne levels is shown in table 3 . Airborne concentrations of glutaraldehyde found in six x ray darkrooms were low, with all 19 samples collected being less than 0.009 mg/m3.
Discussion
Seven of the eight subjects investigated had occupational asthma confirmed by serial peak flow recordings and this was shown to be due to glutaraldehyde by specific bronchial challenge testing. The eighth subject had a negative bronchial challenge test and is unlikely to have occupational asthma due to glutaraldehyde. Three subjects had positive tests to formaldehyde suggesting crossreactivity between the two substances. Most of the reactions were late reactions, although two had an additional early reaction starting within 30 minutes after exposure. It is unlikely that the effect of glutaraldehyde on the airways was solely as an irritant as there was a latent interval after first exposure, the induced reactions were predominantly late rather than early, there was little relationship with baseline histamine responsiveness (four of the seven reactors had normal responsiveness before the challenge), and changes in This is the first series of workers to be described with occupational asthma due to glutaraldehyde and it confirms that glutaraldehyde asthma does exist. Its existence should be borne in mind when dealing with health care workers who complain of asthmatic symptoms that improve on days away from work. It indicates also that action should be taken to prevent further cases of occupational asthma arising. The best option would be to replace glutaraldehyde with a safer agent. There is scope to replace glutaraldehyde with steam sterilisation in most circumstances in the ward, clinic, and for dental use. However, other sterilising chemicals are generally less effective at endoscope sterilisation and may damage the instrument. '5 It is also possible that the biological features that confer good sterilisation properties may be responsible for allergenic properties and that other sterilising agents may also cause occupational asthma, rhinitis, and dermatitis. This is true of formaldehyde, chlorhexidine, isothiazolinones, and chloramine. In practice, therefore, glutaraldehyde should be replaced by steam sterilisation wherever possible. Where instruments are not autoclavable they should be processed in totally enclosed automatic washers, bearing in mind that specific steps should also be taken to protect the operator when refilling and draining disinfection tanks. Ventilation of these washers should be to the outside.
